tirzepatide and ra Semaglutide changed the category. changed the outcome. Retatrutide may raise the ceiling. Here's what separates them. All three activate the GLP-1 receptor, reducing appetite slowing gastric emptying. The difference is The Promise of Injectable GLP-1

But it doesnt have the same name recognition or popularity as the newer GLP-1 drugs for a very simple reason: It doesn't work as well, can cause more severe side effects, and patients have to inject it daily rather than weekly

Tirzepatide has emerging and strong cardiovascular data from the SUMMIT trial, which showed a 38% reduction in worsening heart failure events in patients with HFpEF and obesity

Join the Heart 2 Heart VIP Community at dralo.net/community America's Cardiologist | dralo.net Still Have Questions

Stopping produces regain

This CNS-mediated pro-sexual mechanism is mechanistically upstream of, and independent from, the nitric oxide/cGMP/PDE5 pathway targeted by sildenafil (Viagra), tadalafil (Cialis), and other PDE5 inhibitors which act at the vascular/penile smooth muscle level as downstream effectors of a pre-existing arousal signal